Article
Human papillomavirus testing following loop electrosurgical excision procedure identifies women at risk for posttreatment cervical intraepithelial neoplasia grade 2 or 3 disease.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 May 2006
Kreimer Aimée R, Guido Richard S, Solomon Diane, Schiffman Mark, Wacholder Sholom, Jeronimo José, Wheeler Cosette M, Castle Philip E
Abstract excerpt
BACKGROUND: Loop electrosurgical excision procedure (LEEP) is the predominant treatment for cervical intraepithelial neoplasia grade 2 or 3 (CIN2+) in the United States, yet following treatment approximately 10% of women are diagnosed again with CIN2+, necessitating close follow-up of such patients. METHODS: Surveillance strategies using cytology and/or human papillomavirus (HPV) testing were compared among women...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.